Create Account | Sign In: Author or Forum

Search Symptoms


Awake VATS Can Be Safe Option for Some Lung Cancer Patients

June 25, 2018. 12:00 PM CDT. Awake video-assisted thoracoscopic surgery safe, feasible for patients with poor lung function Read article


ASCO: New Assays May Detect Early Lung Cancer in Blood

June 06, 2018 Targeted sequencing, whole-genome sequencing, whole-genome bisulfite sequencing show potential

ASCO: Ovarian Suppression + Tamoxifen Ups Breast CA Survival

June 05, 2018 Increased disease-free, overall survival for premenopausal women with breast cancer

ASCO: mFOLFIRINOX Improves Survival in Pancreatic Cancer

June 04, 2018 And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery

ASCO: Endocrine Tx Noninferior for HR+, HER2− Breast Cancer

June 04, 2018 Similar efficacy for endocrine, chemoendocrine tx for women with midrange 21-gene recurrence score

ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer

June 04, 2018 Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival

ASCO: mCRC Costs Up in Western Washington vs. British Columbia

June 04, 2018 No significant difference between regions in median OS for those receiving, not receiving systemic tx

ASCO: Pembrolizumab Superior for Initial Tx of Advanced NSCLC

June 04, 2018 Improved overall survival versus chemotherapy regardless of the PD-L1 tumor proportion score

ASCO: Few Eligible Smokers Had CT Screen for Lung CA in 2016

May 17, 2018 Most eligible smokers populated in South, which had most screening sites but low screening rate

Early Intervention May Reduce Breast CA-Related Lymphedema

May 04, 2018 Bioimpedance spectroscopy monitoring with early interventions lowers need for aggressive treatment

Screening Mammos Linked to Less Aggressive Tx If Diagnosed

May 04, 2018 Women aged 40 to 49 years with no mammogram have increased odds of positive nodes, larger tumors

Clinical Upstaging of NSCLC Seen With Each Progressive Week

May 01, 2018 For clinical stage 1 NSCLC, 21.7 percent of patients upstaged after 1 week; 31.5 percent after 8 weeks

Adjuvant Pembrolizumab Beneficial in Metastatic NSCLC

April 16, 2018 And, nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden

Adjuvant Pembrolizumab Beneficial in Stage III Melanoma

April 16, 2018 Pembrolizumab linked to significantly longer recurrence-free survival at 15-month follow-up

Cervical Cancer Frequently Diagnosed After Age 65

March 27, 2018 Almost 20 percent of cervical cancer cases are diagnosed in women older than 65

MRI-Targeted Biopsy Noninferior for Prostate Cancer Detection

March 19, 2018 Clinically significant cancer detected in more men in MRI-targeted biopsy versus standard-biopsy group